Kenya: GSK Rebrands to Haleon Kenya After Separation

17 March 2025
Capital FM (Nairobi)
By Phidel Kizito

Nairobi — UK drugmaker GlaxoSmithKline Limited (GSK) has rebranded to Haleon Kenya Limited, effective March 14, 2025.

The rebrand comes after GSK transferred its consumer health business to Haleon to focus on innovative drugs.

Haleon will now encompass consumer health brands including Sensodyne, Panadol, Eno, and Scott's Emulsion.

"This transition represents more than just a name change; it's a reaffirmation of our commitment to delivering high-quality, science-driven health solutions tailored specifically for Kenyan consumers," said Mark Pfister, General Manager for Haleon Sub-Saharan Africa.

"As Haleon, we are intensifying our focus on innovation, developing products that combine trusted science with a deep understanding of human needs to meet the evolving healthcare demands of Kenyans."

As part of the rebranding process, the company's product packaging will gradually transition from featuring the GSK logo to the Haleon logo, with some variations in branding expected on store shelves during this period.

Read the original article on Capital FM.

Tagged:
Copyright © 2025 Capital FM. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 500 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.